Novonix (NVNXF) Total Liabilities (2020 - 2025)

Novonix has reported Total Liabilities for 6 years, with the latest figure at $121.2 million in Q4 2025.

• For the quarter ending Q4 2025, Total Liabilities rose 37.0% year-over-year to $121.2 million; the trailing twelve-month figure through Dec 2025 stood at $121.2 million (up 37.0% YoY), and the FY2025 full-year result was $121.2 million, up 37.0% from the prior year.
• Total Liabilities for Q4 2025 stood at $121.2 million, down from $182.8 million in the prior quarter.
• The five-year high for Total Liabilities was $182.8 million in Q2 2025, with the low at $14.2 million in Q2 2021.
• Historically, Total Liabilities has averaged $80.0 million across 5 years, with a median of $79.2 million in 2023.
• Annual changes were most pronounced in 2022 — Total Liabilities surged 278.97% — and 2024, when it rose 4.85%.
• Novonix's Total Liabilities stood at $47.2 million in 2021, then climbed by 8.78% to $51.4 million in 2022, then soared by 54.58% to $79.4 million in 2023, then grew by 11.46% to $88.5 million in 2024, then soared by 37.0% to $121.2 million in 2025.
• The last three Total Liabilities figures came in at $121.2 million (Q4 2025), $182.8 million (Q2 2025), and $88.5 million (Q4 2024), per Business Quant data.